Showing results (31-40 of 140) with videos related to
Sort By:
Pageof 14
Investigative Ophthalmology & Visual Science|January 1, 2016
Abnormal Glycogen Storage by Retinal Neurons in DiabetesTom A Gardiner, Paul Canning, Nuala Tipping, et al.Plos One|October 14, 2014
Angiogenic potential of vitreous from Proliferative Diabetic Retinopathy and Eales' Disease patientsPonnalagu Murugeswari, Dhananjay Shukla, Ramasamy Kim, et al.Disease Models & Mechanisms|September 6, 2023
IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathyJosy Augustine, Sofia Pavlou, Kevin Harkin, et al.Journal of Diabetes Research|June 25, 2015
Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsPoojitha Rajasekar, Christina L O'Neill, Lydia Eeles, et al.Frontiers in Endocrinology|May 1, 2014
Endothelial progenitor cells in diabetic retinopathyNoemi Lois, Rachel V McCarter, Christina O'Neill, et al.Antioxidants (Basel, Switzerland)|July 29, 2023
Aldehyde Dehydrogenase and Aldo-Keto Reductase Enzymes: Basic Concepts and Emerging Roles in Diabetic RetinopathyBurak Mugdat Karan, Karis Little, Josy Augustine, et al.Journal of Biochemical and Molecular Toxicology|October 15, 2009
Upregulation of oxidative stress markers in human microvascular endothelial cells by complexes of serum albumin and digestion products of glycated caseinPermal Deo, Josephine V Glenn, Lesley A Powell, et al.Current Eye Research|December 16, 2006
Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier functionMatthew Campbell, Ross Collery, Alice McEvoy, et al.The American Journal of Pathology|January 12, 2002
Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxia-induced retinal neovascularizationDorota Gebarowska, Alan W Stitt, Thomas A Gardiner, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 24, 2021
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687Marc Vanhove, Jean-Marc Wagner, Bernard Noppen, et al.Pageof 14